$PMDI
PSYCHEMEDICS CORP Stock $pmdi

$pmdi Overview Financials Valuation SEC Filings Company Website

2020 Q2 Form 10-Q Financial Statement

#000117184320005910 Filed on August 13, 2020

Income Statement

Concept	2020 Q2	2019 Q2
Revenue	$3.314M	$9.289M
YoY Change	-64.32%	-13.89%
Cost Of Revenue	$3.566M	$5.120M
YoY Change	-30.35%	-8.82%
Gross Profit	-$252.0K	$4.169M
YoY Change	-106.04%	-19.39%
Gross Profit Margin	-7.6%	44.88%
Selling, General & Admin	$2.709M	$2.443M
YoY Change	10.89%	-11.42%
% of Gross Profit		58.6%
Research & Development	$345.0K	$400.0K
YoY Change	-13.75%	11.73%
% of Gross Profit		9.59%
Depreciation & Amortization	$680.0K	$740.0K
YoY Change	-8.11%	-5.13%
% of Gross Profit		17.75%
Operating Expenses	$3.054M	$2.843M
YoY Change	7.42%	-8.76%
Operating Profit	-$3.306M	$1.326M
YoY Change	-349.32%	-35.51%
Interest Expense	-$40.00K	$20.00K
YoY Change	-300.0%	-28.57%
% of Operating Profit		1.51%
Other Income/Expense, Net	-$39.00K	$22.00K
YoY Change	-277.27%	-8.33%
Pretax Income	-$3.345M	$1.348M
YoY Change	-348.15%	-35.19%
Income Tax	-$1.295M	$580.0K
% Of Pretax Income		43.03%
Net Earnings	-$2.050M	$768.0K
YoY Change	-366.93%	-34.75%
Net Earnings / Revenue	-61.86%	8.27%
Basic Earnings Per Share	-$0.37	$0.14
Diluted Earnings Per Share	-$0.37	$0.14
COMMON SHARES
Basic Shares Outstanding	5.523M	5.514M
Diluted Shares Outstanding	5.523M	5.523M

Balance Sheet

Concept	2020 Q2	2019 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$3.670M	$7.097M
YoY Change	-48.29%	-8.07%
Cash & Equivalents	$3.672M	$7.097M
Short-Term Investments		$0.00
Other Short-Term Assets	$1.500M	$1.700M
YoY Change	-11.76%	15.65%
Inventory
Prepaid Expenses
Receivables	$2.560M	$4.526M
Other Receivables	$2.030M	$0.00
Total Short-Term Assets	$9.754M	$13.32M
YoY Change	-26.79%	-7.36%
LONG-TERM ASSETS
Property, Plant & Equipment	$10.37M	$9.503M
YoY Change	9.17%	-14.61%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$920.0K	$893.0K
YoY Change	3.02%	-2.4%
Total Long-Term Assets	$16.02M	$11.81M
YoY Change	35.64%	-1.93%
TOTAL ASSETS
Total Short-Term Assets	$9.754M	$13.32M
Total Long-Term Assets	$16.02M	$11.81M
Total Assets	$25.78M	$25.14M
YoY Change	2.55%	-4.88%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$61.00K	$704.0K
YoY Change	-91.34%	-36.97%
Accrued Expenses	$1.649M	$2.220M
YoY Change	-25.72%	-26.34%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$683.0K	$416.0K
YoY Change	64.18%	-56.53%
Total Short-Term Liabilities	$3.283M	$4.201M
YoY Change	-21.85%	-17.43%
LONG-TERM LIABILITIES
Long-Term Debt	$3.789M	$1.005M
YoY Change	277.01%	-48.25%
Other Long-Term Liabilities	$4.300M	$560.0K
YoY Change	667.86%
Total Long-Term Liabilities	$3.789M	$1.005M
YoY Change	277.01%	-48.25%
TOTAL LIABILITIES
Total Short-Term Liabilities	$3.283M	$4.201M
Total Long-Term Liabilities	$3.789M	$1.005M
Total Liabilities	$11.85M	$6.658M
YoY Change	78.01%	-18.49%
SHAREHOLDERS EQUITY
Retained Earnings	-$6.956M	-$1.916M
YoY Change	263.05%	27.99%
Common Stock	$32.60M	$31.84M
YoY Change	2.37%	1.92%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$10.08M	$10.08M
YoY Change	0.0%	0.0%
Treasury Stock Shares	$668.0K	$668.0K
Shareholders Equity	$13.92M	$18.48M
YoY Change
Total Liabilities & Shareholders Equity	$25.78M	$25.14M
YoY Change	2.55%	-4.88%

Cashflow Statement

Concept	2020 Q2	2019 Q2
OPERATING ACTIVITIES
Net Income	-$2.050M	$768.0K
YoY Change	-366.93%	-34.75%
Depreciation, Depletion And Amortization	$680.0K	$740.0K
YoY Change	-8.11%	-5.13%
Cash From Operating Activities	-$3.320M	$1.320M
YoY Change	-351.52%	-39.73%
INVESTING ACTIVITIES
Capital Expenditures	-$340.0K	-$230.0K
YoY Change	47.83%	-20.69%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$3.800M
YoY Change	-100.0%	-12766.67%
Cash From Investing Activities	-$350.0K	$3.580M
YoY Change	-109.78%	-1218.75%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	2.000M	-1.130M
YoY Change	-276.99%	-14.39%
NET CHANGE
Cash From Operating Activities	-3.320M	1.320M
Cash From Investing Activities	-350.0K	3.580M
Cash From Financing Activities	2.000M	-1.130M
Net Change In Cash	-1.670M	3.770M
YoY Change	-144.3%	585.45%
FREE CASH FLOW
Cash From Operating Activities	-$3.320M	$1.320M
Capital Expenditures	-$340.0K	-$230.0K
Free Cash Flow	-$2.980M	$1.550M
YoY Change	-292.26%	-37.5%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
	dei	Document Period End Date DocumentPeriodEndDate	2020-06-30
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2020
	dei	Document Type DocumentType	10-Q
	dei	Amendment Flag AmendmentFlag	false
CY2020Q2	pmd	Income Tax Benefit Cares Act IncomeTaxBenefitCARESAct	1300000
	pmd	Income Tax Benefit Cares Act IncomeTaxBenefitCARESAct	1500000
	pmd	Increase Decrease In Accrued Expenses And Accrued Income Taxes IncreaseDecreaseInAccruedExpensesAndAccruedIncomeTaxes	-2084000
	pmd	Increase Decrease In Accrued Expenses And Accrued Income Taxes IncreaseDecreaseInAccruedExpensesAndAccruedIncomeTaxes	-745000
	pmd	Increase Decrease In Operating Lease Rou Assets And Liabilities IncreaseDecreaseInOperatingLeaseROUAssetsAndLiabilities	-490000
	pmd	Increase Decrease In Operating Lease Rou Assets And Liabilities IncreaseDecreaseInOperatingLeaseROUAssetsAndLiabilities	-511000
CY2020Q2	pmd	Lessee Operating Lease Liability Payments Due Year Six LesseeOperatingLeaseLiabilityPaymentsDueYearSix	458000
	pmd	Payments Of Equipment Financing PaymentsOfEquipmentFinancing	338000
	pmd	Payments Of Equipment Financing PaymentsOfEquipmentFinancing	207000
	pmd	Rightofuse Asset Amortization RightofuseAssetAmortization	493000
	pmd	Rightofuse Asset Amortization RightofuseAssetAmortization	511000
CY2020Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	61000
CY2019Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	617000
CY2020Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2560000
CY2019Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	3780000
CY2020Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1649000
CY2019Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	3577000
CY2020Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	15565000
CY2019Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	16197000
CY2020Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1633000
CY2019Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1624000
CY2020Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	32564000
CY2019Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	32249000
	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	8000
	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	33000
	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	323000
	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	319000
CY2020Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	160000
CY2019Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	161000
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	323000
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	319000
CY2020Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	28000
CY2019Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	45000
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	594000
CY2020Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	594000
CY2020Q2	us-gaap	Assets Assets	25776000
CY2019Q4	us-gaap	Assets Assets	27531000
CY2020Q2	us-gaap	Assets Current AssetsCurrent	9754000
CY2019Q4	us-gaap	Assets Current AssetsCurrent	12851000
CY2020Q2	us-gaap	Cash Cash	3672000
CY2019Q4	us-gaap	Cash Cash	7283000
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	7283000
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	4069000
CY2020Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	3672000
CY2019Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	7097000
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-3611000
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	3028000
CY2020Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2019Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.18
	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.36
CY2020Q2	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared
CY2019Q2	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.18
CY2020Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.005
CY2019Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.005
CY2020Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000
CY2019Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000
CY2020Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	6195000
CY2019Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	6185000
CY2020Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	6195000
CY2019Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	6185000
CY2020Q2	us-gaap	Common Stock Value CommonStockValue	31000
CY2019Q4	us-gaap	Common Stock Value CommonStockValue	31000
CY2020Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-2037000
CY2019Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	850000
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-2219000
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	1429000
CY2020Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	3566000
CY2019Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	5120000
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	8375000
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	10534000
CY2020Q2	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	476000
CY2019Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	550000
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1288000
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1501000
CY2019Q2	us-gaap	Gross Profit GrossProfit	4169000
	us-gaap	Description Of New Accounting Pronouncements Not Yet Adopted DescriptionOfNewAccountingPronouncementsNotYetAdopted	<div style="display: inline; font-family: times new roman; font-size: 10pt"><table cellpadding="0" cellspacing="0" style="; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; min-width: 700px;"> <tr style="vertical-align: top"> <td style="width: 0"></td> <td style="width: 0.25in"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font: inherit;">13.</div></div></td> <td><div style="display: inline; font-weight: bold;">Accounting Pronouncements Issued But <div style="display: inline; font-style: italic; font: inherit;">Not</div> Yet Effective</div></td> </tr> </table> <div style=" font-size: 10pt; margin: 0pt 0"></div> <div style=" font-size: 10pt; margin: 0pt 0"> </div> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.25in; margin: 0pt 0">During the quarter there were <div style="display: inline; font-style: italic; font: inherit;">no</div> recent accounting pronouncements affecting the Company.</div></div>
	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	993000
	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	1985000
CY2020Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.37
CY2019Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.14
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.40
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.25
CY2020Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.37
CY2019Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.14
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.40
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.25
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-47000
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	95000
	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-94000
	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets
CY2020Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1853000
CY2019Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1355000
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3386000
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3270000
CY2020Q2	us-gaap	Gross Profit GrossProfit	-252000
	us-gaap	Gross Profit GrossProfit	2476000
	us-gaap	Gross Profit GrossProfit	8577000
CY2020Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-3345000
CY2019Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	1348000
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-3660000
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	2318000
CY2020Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1295000
CY2019Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	580000
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1451000
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	923000
	us-gaap	Income Taxes Paid IncomeTaxesPaid	229000
	us-gaap	Income Taxes Paid IncomeTaxesPaid	1499000
CY2020Q2	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	2026000
CY2019Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-556000
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-428000
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-1220000
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-303000
	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	74000
	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	58000
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1734000
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	633000
	us-gaap	Interest Paid Net InterestPaidNet	43000
	us-gaap	Interest Paid Net InterestPaidNet	38000
CY2020Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	5770000
CY2020Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	1041000
CY2020Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	593000
CY2020Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	1035000
CY2020Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	1096000
CY2020Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	1028000
CY2020Q2	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	519000
CY2020Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	576000
CY2020Q2	us-gaap	Liabilities Liabilities	11852000
CY2019Q4	us-gaap	Liabilities Liabilities	10711000
CY2020Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	25776000
CY2019Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	27531000
CY2020Q2	us-gaap	Liabilities Current LiabilitiesCurrent	3283000
CY2019Q4	us-gaap	Liabilities Current LiabilitiesCurrent	5835000
CY2020Q2	us-gaap	Long Term Debt Current LongTermDebtCurrent	683000
CY2019Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	678000
CY2020Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	3789000
CY2019Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1951000
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	842000
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-2225000
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-677000
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	3468000
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-3729000
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1690000
	us-gaap	Net Income Loss NetIncomeLoss	-2209000
	us-gaap	Net Income Loss NetIncomeLoss	1395000
CY2020Q2	us-gaap	Net Income Loss NetIncomeLoss	-2050000
CY2019Q2	us-gaap	Net Income Loss NetIncomeLoss	768000
	us-gaap	Noncash Or Part Noncash Acquisition Fixed Assets Acquired1 NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1	193000
	us-gaap	Noncash Or Part Noncash Acquisition Fixed Assets Acquired1 NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1	450000
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1
CY2020Q2	us-gaap	Operating Expenses OperatingExpenses	3054000
CY2019Q2	us-gaap	Operating Expenses OperatingExpenses	2843000
	us-gaap	Operating Expenses OperatingExpenses	6024000
	us-gaap	Operating Expenses OperatingExpenses	6307000
CY2020Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-3306000
CY2019Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	1326000
	us-gaap	Operating Income Loss OperatingIncomeLoss	-3548000
	us-gaap	Operating Income Loss OperatingIncomeLoss	2270000
CY2020Q2	us-gaap	Operating Lease Expense OperatingLeaseExpense	257000
	us-gaap	Operating Lease Expense OperatingLeaseExpense	564000
CY2020Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	5194000
CY2020Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	890000
CY2019Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	963000
CY2020Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	4304000
CY2019Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2375000
	us-gaap	Operating Lease Payments OperatingLeasePayments	519000
	us-gaap	Operating Lease Payments OperatingLeasePayments	523000
CY2020Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	4728000
CY2019Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2875000
CY2020Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.039
CY2020Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P5Y146D
CY2020Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	920000
CY2019Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	943000
CY2020Q2	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent	13000
CY2019Q2	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent	82000
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent	-10000
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent	34000
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-9000
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	34000
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-36000
CY2020Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-39000
CY2019Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	22000
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-112000
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	48000
	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	7000
	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-14000
	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	993000
	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	1985000
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	8000
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	33000
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	675000
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	165000
	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	135000
	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	191000
CY2020Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.005
CY2019Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.005
CY2020Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	873000
CY2019Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	873000
CY2020Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2019Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2020Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2019Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2020Q2	us-gaap	Preferred Stock Value PreferredStockValue
CY2019Q4	us-gaap	Preferred Stock Value PreferredStockValue
CY2020Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1496000
CY2019Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1788000
	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	2181000
	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	140000
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment
	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments
	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	3810000
CY2020Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	10374000
CY2019Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	10862000
	us-gaap	Share Based Compensation ShareBasedCompensation	323000
	us-gaap	Share Based Compensation ShareBasedCompensation	319000
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	584000
CY2020Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	581000
CY2020Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	345000
CY2019Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	400000
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	676000
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	820000
CY2020Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-6956000
CY2019Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-3754000
CY2020Q2	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	3314000
CY2019Q2	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	9289000
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	10851000
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	19111000
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	2346000
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	1927000
CY2020Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	856000
CY2019Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1088000
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1962000
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	2217000
CY2020Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	386000
CY2020Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	15.62
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	3000
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
CY2020Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	16820000
CY2020Q2	us-gaap	Stockholders Equity StockholdersEquity	13924000
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	18747000
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	14.94
CY2020Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	14.93
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	4.37
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
CY2020Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P6Y328D
CY2019	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y328D
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y146D
CY2019Q2	us-gaap	Stockholders Equity StockholdersEquity	18477000
CY2020Q2	us-gaap	Treasury Stock Shares TreasuryStockShares	668000
CY2019Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	668000
CY2020Q2	us-gaap	Treasury Stock Value TreasuryStockValue	10082000
CY2019Q4	us-gaap	Treasury Stock Value TreasuryStockValue	10082000
CY2020Q2	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment
CY2019Q2	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	9000
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	25000
CY2020Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5523000
CY2019Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5523000
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5520000
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5535000
CY2020Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5523000
CY2019Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5514000
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5520000
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5510000

Files In Submission

Name	View Source	Status
0001171843-20-005910-index-headers.html	Edgar Link	pending
0001171843-20-005910-index.html	Edgar Link	pending
0001171843-20-005910.txt	Edgar Link	pending
0001171843-20-005910-xbrl.zip	Edgar Link	pending
exh_311.htm	Edgar Link	pending
exh_312.htm	Edgar Link	pending
exh_321.htm	Edgar Link	pending
exh_322.htm	Edgar Link	pending
f10q_081320p.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
pmd-20200630.xml	Edgar Link	completed
pmd-20200630.xsd	Edgar Link	pending
pmd-20200630_cal.xml	Edgar Link	unprocessable
pmd-20200630_def.xml	Edgar Link	unprocessable
pmd-20200630_lab.xml	Edgar Link	unprocessable
pmd-20200630_pre.xml	Edgar Link	unprocessable
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$PMDI
PSYCHEMEDICS CORP Stock $pmdi

2020 Q2 Form 10-Q Financial Statement

#000117184320005910 Filed on August 13, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PMDI PSYCHEMEDICS CORP Stock $pmdi

2020 Q2 Form 10-Q Financial Statement

#000117184320005910 Filed on August 13, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PMDI
PSYCHEMEDICS CORP Stock $pmdi